New shot aims to shield cancer patients from Chemo's dangerous side effect
NCT ID NCT06711523
Summary
This study is testing a new, longer-lasting injection to prevent a dangerous drop in white blood cells (neutropenia) after chemotherapy. It involves 250 women with breast cancer and compares the new injection to an existing standard treatment. The goal is to see if the new version is as safe and effective at keeping infection-fighting cells at safer levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Conditions
Explore the condition pages connected to this study.